3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid,
MK 0752,
MK-0752,
MK0752,
MK-0752,
471905-41-6,
MK0752,
cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid,
UNII-9JD9B4S53T,
MK 0752,
9JD9B4S53T,
3-((1r,4s)-4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid,
3-((1r,4s)-4-(4-chlorophenylsulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid,
3-(cis-4-((4-Chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid,
952578-68-6,
cc-14,
C21H21ClF2O4S,
MLS006011072,
SCHEMBL756247,
SCHEMBL756248,
SCHEMBL756249,
CHEMBL3392635,
SCHEMBL18288908,
KS-00001CTM,
HMS3656H09,
AOB87197,
BCP05305,
EX-A2100,
ABP000306,
MFCD21608529,
RW3012,
s2660,
ZINC33965716,
AKOS024462903,
AKOS026750568,
ZINC100015572,
ZINC100015575,
BCP9000935,
BCP9000936,
CS-0253,
DB12852,
MK-0752/MK0752,
QC-1905,
RL03744,
SB16673,
3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoic Acid,
Cyclohexanepropanoic acid, 4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)-, cis-,
NCGC00263184-01,
BC620486,
HY-10974,
SC-85593,
SMR004702862,
AB0007907,
FT-0752638,
ST24041580,
SW219755-1,
X7591,
W-5847,
J-520085,
cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluoroph,
L-000891675,
471905-41-6, MK0752, MK 0752,
3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid,
3-[(1s,4r)-4-(4-chlorobenzenesulfonyl)-4-(2,5-difluorophenyl)cyclohexyl]propanoic acid,
4beta-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexane-1beta-propanoic acid,
3-((1R,4S)-4-(4-chlorophenylsulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid, 98%, a moderately potent |A-secretase inhibitor,
D02HNG,
XCGJIFAKUZNNOR-UHFFFAOYSA-N,
CID9803433,
A4006,
A11194,
3-((1R,4S)-4-(4-chlorophenylsulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid, 98%, a moderately potent gamma-secretase inhibitor - 10MG 10mg,